ABNORMALITIES of respiratory function have been observed in scleroderma. 1–5 However, little attention has been paid to the study of the pulmonary function of patients with systemic lupus ...

Patients diagnosed with systemic sclerosis-related pulmonary hypertension in the last 10 years had better survival than those diagnosed prior, according to results published in American Journal of ...

The Food and Drug Administration (FDA) has approved Actemra ® (tocilizumab; Genentech) subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is characterized by chronic inflammation in both the pulmonary compartment and the rest of ...

Systemic sclerosis (SSc) is a disabling autoimmune disorder that can cause diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs. Affecting approximately 2 million ...

MANCHESTER, England — Use of immunosuppressive drugs within 5 years of the onset of systemic sclerosis (SSc) did not lower patients’ risk for developing pulmonary arterial hypertension (PAH ...

Credit: Shutterstock. Researchers studied the changes of pulmonary artery systolic pressure among patients with interstitial lung disease associated with systemic sclerosis receiving rituximab ...

Systemic to pulmonary arterial shunts are surgically created connections between the aorta and a pulmonary artery in children with cyanotic congenital heart disease, such as tetralogy of Fallot or ...